Halozyme Therapeutics, Inc. (HALO) - NASDAQ
From other sites
Company Description
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel oncology therapies that target the tumor microenvironment. Its investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing increased access of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States